Skip to Main Content

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. 

Telehealth providers stay nimble amid regulatory uncertainty 


A handful of online abortion medication providers told me they were anxiously awaiting the Supreme Court’s ruling on mifepristone last week — a decision that risks dramatically altering their operations by limiting the types of medication they could dispense via mail. Mifepristone is often used in combination with misopristol to end a pregnancy, though misopristol can also be used on its own.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.